Click here to apply!

MCCB Publications

Mishra AK et al. (2024) Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer.
Article | Green Lab

Cong K et al. (2024) FANCJ promotes PARP1 activity during DNA replication that is essential in BRCA1 deficient cells.
Article | Cantor Lab

Lee N et al. (2024) Selenium reduction of ubiquinone via SQOR suppresses ferroptosis.
Article | Kim Lab

Kim S et al. (2024) Regulation of proteostasis and innate immunity via mitochondria-nuclear communication.
Article | Haynes Lab 

Roderick-Richardson JE et al. (2024) ZBP1 activation triggers hematopoietic stem and progenitor cell death resulting in bone marrow failure in mice.
Article | Kelliher Lab

Wang F et al. (2023) Roles of the Rlim-Rex1 axis during X chromosome inactivation in mice.
Article | Bach Lab

Mukhopadhyay D et al. (2023) The calcium channel TRPC6 promotes chemotherapy-induced persistence by regulating integrin α6 mRNA splicing.
Article | Mercurio Lab

Doshi MB et al. (2023) Disruption of sugar nucleotide clearance is a therapeutic vulnerability of cancer cells.
Article | Kim Lab

Ahmad MH et al. (2023) Runx1-R188Q germline mutation induces inflammation and predisposition to hematologic malignancies in mice.
Article | Castilla Lab

Shin M et al. (2023) Generation and application of endogenously floxed alleles for cell-specific knockout in zebrafish.
Article | Lawson Lab

Wang R et al. (2023) PINK1, Keap1, and Rtnl1 regulate selective clearance of endoplasmic reticulum during development.
Article | Baehrecke Lab

Liang SQ et al. (2023) Genome-wide profiling of prime editor off-target sites in vitro and in vivo using PE-tag.
Article | Wolfe Lab

Xu Z et al. (2023) Inhibition of VEGF binding to neuropilin-2 enhances chemosensitivity and inhibits metastasis in triple-negative breast cancer.
Article | Mercurio Lab

Conti MM et al. (2023) Phosphosite Scanning reveals a complex phosphorylation code underlying CDK-dependent activation of Hcm1. 
Article | Benanti Lab

Chibaya L et al. (2023) EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance.
Article | Ruscetti Lab

More Publications...